• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec1
Multiple Executives of ZhaoYan New Drug Completed their Stock Sale Plans
10:14
Nov27
Director Sun Yunxia of Zhaoyan New Drug Reduces 100,000 Shares
12:03
Nov14
Directors of Zhaoyan New Drug Reduced Shares
12:03
Nov13
Huaxi Securities Maintains '增持' Rating for Zhaoyan Pharmaceutical, Predicts Future Demand Improvement
06:44
Nov4
Executives of Syneos Health China Cut Shares Held
12:04
Oct30
JOINN released FY2025 9 Months Earnings on October 30 During-Market (BJT) with actual revenue of CNY 984.96 M and EPS of CNY 0.1074
01:00

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 316.39 M, Net Income 19.77 M, EPS 0.0291

Aug26
Earning Release(CST)

FY2025 Q2 Earning Release (CNY) Revenue 381.24 M, Net Income 19.81 M, EPS 0.0282

Aug14
Distribution Plan(CST)

Cash dividend 0.03 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More